News
MedPage Today on MSN2d
Upfront T-DXd Combo Nearly Doubles PFS in HER2-Positive Breast CancerAt the recent American Society of Clinical Oncology (ASCO) annual meeting, interim results from the DESTINY-Breast09 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback